Impact of Antibiotic Prophylaxis on Gut Microbiota in Colorectal Surgery: Insights from an Eastern European Stewardship Study

Overview

Journal Front Cell Infect Microbiol

Date 2025 Jan 28

PMID 39872941

Authors

Irina Cezara Vacarean-Trandafir

Roxana-Maria Amarandi

Iuliu Cristian Ivanov

Loredana Mihaiela Dragos

Mihaela Mentel

Stefan Iacob

Ana-Maria Musina

Elena-Roxana Bargaoanu

Cristian Ene Roata

Stefan Morarasu

Valeri Tutuianu

Marcel Ciobanu

Mihail-Gabriel Dimofte

Affiliations

Soon will be listed here.

Abstract

Introduction: Antibiotic overuse is driving a global rise in antibiotic resistance, highlighting the need for robust antimicrobial stewardship (AMS) initiatives to improve prescription practices. While antimicrobials are essential for treating sepsis and preventing surgical site infections (SSIs), they can inadvertently disrupt the gut microbiota, leading to postoperative complications. Treatment methods vary widely across nations due to differences in drug choice, dosage, and therapy duration, affecting antibiotic resistance rates, which can reach up to 51% in some countries. In Romania and the Republic of Moldova, healthcare practices for surgical antibiotic prophylaxis differ significantly despite similarities in genetics, culture, and diet. Romania's stricter healthcare regulations result in more standardized antibiotic protocols, whereas Moldova's limited healthcare funding leads to less consistent practices and greater variability in treatment outcomes.

Methods: This study presents the results of a prospective cross-border investigation involving 86 colorectal cancer patients from major oncological hospitals in Romania and Moldova. We analyzed fecal samples collected from patients before and 7 days post-antibiotic treatment, focusing on the V3-V4 region of the 16S rRNA gene.

Results: Our findings indicate that inconsistent antibiotic prophylaxis policies-varying in type, dosage, or therapy duration-significantly impacted the gut microbiota and led to more frequent dysbiosis compared to stricter prophylactic antibiotic practices (single dose, single product, limited time).

Discussion: We emphasize the need for standardized antibiotic prophylaxis protocols to minimize dysbiosis and its associated risks, promoting more effective antimicrobial use, particularly in low- and middle-income countries (LMICs).

References

Dobson G . Trauma of major surgery: A global problem that is not going away. Int J Surg. 2020; 81:47-54. PMC: 7388795. DOI: 10.1016/j.ijsu.2020.07.017. View

Kamal S, Hyldig N, Krych L, Greisen G, Krogfelt K, Zachariassen G . Impact of Early Exposure to Cefuroxime on the Composition of the Gut Microbiota in Infants Following Cesarean Delivery. J Pediatr. 2019; 210:99-105.e2. DOI: 10.1016/j.jpeds.2019.03.001. View

Rollins K, Javanmard-Emamghissi H, Acheson A, Lobo D . The Role of Oral Antibiotic Preparation in Elective Colorectal Surgery: A Meta-analysis. Ann Surg. 2018; 270(1):43-58. PMC: 6570620. DOI: 10.1097/SLA.0000000000003145. View

Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag C, Laversanne M . Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023; 72(2):338-344. DOI: 10.1136/gutjnl-2022-327736. View

Arriola V, Tischendorf J, Musuuza J, Barker A, Rozelle J, Safdar N . Assessing the Risk of Hospital-Acquired Clostridium Difficile Infection With Proton Pump Inhibitor Use: A Meta-Analysis. Infect Control Hosp Epidemiol. 2016; 37(12):1408-1417. PMC: 5657489. DOI: 10.1017/ice.2016.194. View

Hunter P . The cancer microbiome: The discovery and study of tumour-specific cancer microbiomes have given rise to new therapeutic options: The discovery and study of tumour-specific cancer microbiomes have given rise to new therapeutic options. EMBO Rep. 2023; 24(4):e57040. PMC: 10074096. DOI: 10.15252/embr.202357040. View

Callahan B, Sankaran K, Fukuyama J, McMurdie P, Holmes S . Bioconductor Workflow for Microbiome Data Analysis: from raw reads to community analyses. F1000Res. 2016; 5:1492. PMC: 4955027. DOI: 10.12688/f1000research.8986.2. View

Rodemann J, Dubberke E, Reske K, Seo D, Stone C . Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007; 5(3):339-44. DOI: 10.1016/j.cgh.2006.12.027. View

Ananthakrishnan A, Issa M, Binion D . Clostridium difficile and inflammatory bowel disease. Gastroenterol Clin North Am. 2009; 38(4):711-28. DOI: 10.1016/j.gtc.2009.07.003. View

10.

Belizario J, Faintuch J . Microbiome and Gut Dysbiosis. Exp Suppl. 2018; 109:459-476. DOI: 10.1007/978-3-319-74932-7_13. View

11.

Patrick D, Hutchinson J . Antibiotic use and population ecology: how you can reduce your "resistance footprint". CMAJ. 2009; 180(4):416-21. PMC: 2638037. DOI: 10.1503/cmaj.080626. View

12.

Baur D, Gladstone B, Burkert F, Carrara E, Foschi F, Dobele S . Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infect Dis. 2017; 17(9):990-1001. DOI: 10.1016/S1473-3099(17)30325-0. View

13.

Huang H, Zhong W, Wang X, Yang Y, Wu T, Chen R . The role of gastric microecological dysbiosis in gastric carcinogenesis. Front Microbiol. 2023; 14:1218395. PMC: 10423824. DOI: 10.3389/fmicb.2023.1218395. View

14.

Charani E, Smith I, Skodvin B, Perozziello A, Lucet J, Lescure F . Investigating the cultural and contextual determinants of antimicrobial stewardship programmes across low-, middle- and high-income countries-A qualitative study. PLoS One. 2019; 14(1):e0209847. PMC: 6335060. DOI: 10.1371/journal.pone.0209847. View

15.

Schlebusch S, Graham R, Jennison A, Lassig-Smith M, Harris P, Lipman J . Standard rectal swabs as a surrogate sample for gut microbiome monitoring in intensive care. BMC Microbiol. 2022; 22(1):99. PMC: 9004175. DOI: 10.1186/s12866-022-02487-0. View

16.

Pandey H, Tang D, Wong S, Lal D . Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities. Cancers (Basel). 2023; 15(3). PMC: 9913759. DOI: 10.3390/cancers15030866. View

17.

Poggio J . Perioperative strategies to prevent surgical-site infection. Clin Colon Rectal Surg. 2014; 26(3):168-73. PMC: 3747289. DOI: 10.1055/s-0033-1351133. View

18.

Pilmis B, Monnier A, Zahar J . Gut Microbiota, Antibiotic Therapy and Antimicrobial Resistance: A Narrative Review. Microorganisms. 2020; 8(2). PMC: 7074698. DOI: 10.3390/microorganisms8020269. View

19.

Butt S, Ahmad M, Saeed H, Saleem Z, Javaid Z . Post-surgical antibiotic prophylaxis: Impact of pharmacist's educational intervention on appropriate use of antibiotics. J Infect Public Health. 2019; 12(6):854-860. DOI: 10.1016/j.jiph.2019.05.015. View

20.

Artinyan A, Orcutt S, Anaya D, Richardson P, Chen G, Berger D . Infectious postoperative complications decrease long-term survival in patients undergoing curative surgery for colorectal cancer: a study of 12,075 patients. Ann Surg. 2014; 261(3):497-505. DOI: 10.1097/SLA.0000000000000854. View